Health
Chinese COVID vaccine candidate based on inactivated virus appears safe, induces immune response, study finds – Medical Xpress
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today…
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.
Antibody responses could be induced within 28 days of the first immunisation, by giving two doses of the vaccine candidate 14 days apart.
The study also identifies the optimum dose…
-
General23 hours agoPrince Harry arrives in Kyiv to meet with wounded Ukrainian war veterans
-
Noosa News22 hours agoSeaWorld rescuers battle rough seas to free entangled humpback whale
-
General20 hours agoCharlie Kirk shooting suspect is in custody, Donald Trump says
-
Noosa News24 hours agoLockyer Valley Correctional Centre, Queensland’s largest prison, takes first inmates